Report cover image

Global Radiopharmaceutical Injector Supply, Demand and Key Producers, 2026-2032

Publisher GlobalInfoResearch
Published Jan 16, 2026
Length 114 Pages
SKU # GFSH20743853

Description

The global Radiopharmaceutical Injector market size is expected to reach $ 57.02 million by 2032, rising at a market growth of 7.2% CAGR during the forecast period (2026-2032).

A radiopharmaceutical injector is a medical device used to administer radiopharmaceuticals to patients. Radiopharmaceuticals are drugs that contain radioactive isotopes, which emit gamma rays or positrons that can be detected by specialized imaging equipment. These drugs are used in nuclear medicine for diagnostic imaging and therapy.

The radiopharmaceutical injector is specifically designed to safely and accurately deliver these radioactive drugs into the patient"s body. It ensures precise control over the injection process, including the injection rate, volume, and timing. This control is crucial to ensure optimal distribution of the radiopharmaceutical within the patient"s body and accurate imaging or therapeutic results.

Global key players of Radiopharmaceutical Injector include Medrad, Inc.(Bayer), UNIVERSAL GIKEN and Comecer, etc. The top three players hold a share over 65%. Medrad, Inc.(Bayer) is the largest manufacturers of Radiopharmaceutical Injector in the world, has a share about 30%. Europe is the largest market, has a share about 35%. In terms of product type, PET Radioactive Drugs Injector is the largest segment, occupied for a share of 85%, and in terms of application, Hospitals and Clinics has a share about 80 percent.

This report studies the global Radiopharmaceutical Injector production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Radiopharmaceutical Injector and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiopharmaceutical Injector that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Radiopharmaceutical Injector total production and demand, 2021-2032, (Units)

Global Radiopharmaceutical Injector total production value, 2021-2032, (USD Million)

Global Radiopharmaceutical Injector production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)

Global Radiopharmaceutical Injector consumption by region & country, CAGR, 2021-2032 & (Units)

U.S. VS China: Radiopharmaceutical Injector domestic production, consumption, key domestic manufacturers and share

Global Radiopharmaceutical Injector production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)

Global Radiopharmaceutical Injector production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)

Global Radiopharmaceutical Injector production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)

This report profiles key players in the global Radiopharmaceutical Injector market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medrad, Inc.(Bayer), UNIVERSAL GIKEN, Comecer, Sumitomo Heavy Industries, Tema Sinergie, Lemer Pax, BQSV, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiopharmaceutical Injector market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Radiopharmaceutical Injector Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Radiopharmaceutical Injector Market, Segmentation by Type:
PET Radioactive Drugs Injector
PET and SPECT Radioactive Drugs Injector

Global Radiopharmaceutical Injector Market, Segmentation by Application:
Hospitals and Clinics
R&D Institution

Companies Profiled:
Medrad, Inc.(Bayer)
UNIVERSAL GIKEN
Comecer
Sumitomo Heavy Industries
Tema Sinergie
Lemer Pax
BQSV

Key Questions Answered:

1. How big is the global Radiopharmaceutical Injector market?

2. What is the demand of the global Radiopharmaceutical Injector market?

3. What is the year over year growth of the global Radiopharmaceutical Injector market?

4. What is the production and production value of the global Radiopharmaceutical Injector market?

5. Who are the key producers in the global Radiopharmaceutical Injector market?

6. What are the growth factors driving the market demand?

Table of Contents

114 Pages
1 Supply Summary
2 Demand Summary
3 World Manufacturers Competitive Analysis
4 United States VS China VS Rest of the World
5 Market Analysis by Type
6 Market Analysis by Application
7 Company Profiles
8 Industry Chain Analysis
9 Research Findings and Conclusion
10 Appendix
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.